belinostat 500 MG Injection [Beleodaq]
- RxCUI
- 1543552
- RxNorm name
- belinostat 500 MG Injection [Beleodaq]
- Display name
- belinostat 500 MG Injection [Beleodaq]
- Full name
- belinostat 500 MG Injection [Beleodaq]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:52
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Beleodaq | BELINOSTAT | Acrotech Biopharma Inc | 2e8ef36b-71fa-4492-a16f-577d5f7d111d | 2025-04-07 | Warnings, Adverse reactions | 1543552 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 2e8ef36b-71fa-4492-a16f-577d5f7d111d | Beleodaq 500 MG Injection [PSN] · belinostat 500 MG Injection [Beleodaq] [SBD] · Beleodaq 500 MG Injection [SY] | 3 | 10 | These highlights do not include all the information needed to use BELEODAQ safely and effectively. See full prescribing information for BELEODAQ. BELEODAQ ® (belinostat) for injection, for intravenous use Initial U.S. Approval: 2014 | 20250407 |